Hims & Hers Health (NYSE:HIMS) Shares Gap Down to $13.22

Hims & Hers Health, Inc. (NYSE:HIMS)’s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $13.22, but opened at $12.53. Hims & Hers Health shares last traded at $12.66, with a volume of 1,773,677 shares traded.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on HIMS shares. Canaccord Genuity Group started coverage on shares of Hims & Hers Health in a research report on Wednesday, April 10th. They set a “buy” rating and a $20.00 target price on the stock. Leerink Partnrs restated a “market perform” rating on shares of Hims & Hers Health in a research report on Monday, February 26th. Imperial Capital upgraded shares of Hims & Hers Health from an “in-line” rating to an “outperform” rating and set a $16.00 target price on the stock in a research report on Wednesday, February 28th. Citigroup increased their target price on shares of Hims & Hers Health from $12.00 to $16.00 and gave the stock a “buy” rating in a research report on Tuesday, February 27th. Finally, TheStreet upgraded shares of Hims & Hers Health from a “d” rating to a “c” rating in a research report on Monday, March 4th. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, Hims & Hers Health has a consensus rating of “Moderate Buy” and an average price target of $14.85.

Hims & Hers Health Trading Down 2.4 %

The stock’s fifty day moving average price is $13.42 and its two-hundred day moving average price is $9.78.

Hims & Hers Health (NYSE:HIMS) last issued its quarterly earnings data on Monday, February 26th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.03. The business had revenue of $246.60 million during the quarter, compared to the consensus estimate of $245.84 million. Hims & Hers Health had a negative net margin of 2.70% and a negative return on equity of 7.21%. The firm’s revenue was up 47.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.05) EPS. On average, research analysts forecast that Hims & Hers Health, Inc. will post 0.1 earnings per share for the current year.

Insider Activity at Hims & Hers Health

In related news, CEO Andrew Dudum sold 15,100 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $9.01, for a total value of $136,051.00. Following the completion of the transaction, the chief executive officer now owns 51,653 shares of the company’s stock, valued at approximately $465,393.53. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, CEO Andrew Dudum sold 15,100 shares of the firm’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $9.01, for a total transaction of $136,051.00. Following the completion of the transaction, the chief executive officer now owns 51,653 shares of the company’s stock, valued at $465,393.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Soleil Boughton sold 4,080 shares of the firm’s stock in a transaction on Friday, February 9th. The shares were sold at an average price of $10.03, for a total transaction of $40,922.40. Following the transaction, the insider now directly owns 154,345 shares of the company’s stock, valued at approximately $1,548,080.35. The disclosure for this sale can be found here. Insiders sold a total of 675,838 shares of company stock valued at $8,487,125 in the last quarter. Insiders own 31.63% of the company’s stock.

Hedge Funds Weigh In On Hims & Hers Health

Several large investors have recently modified their holdings of the business. Counterpoint Mutual Funds LLC bought a new position in shares of Hims & Hers Health during the first quarter valued at $285,000. Fragasso Group Inc. bought a new position in shares of Hims & Hers Health during the first quarter valued at $243,000. Los Angeles Capital Management LLC increased its position in shares of Hims & Hers Health by 58.5% during the first quarter. Los Angeles Capital Management LLC now owns 28,206 shares of the company’s stock worth $436,000 after buying an additional 10,405 shares during the period. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Hims & Hers Health during the fourth quarter worth $155,000. Finally, Vanguard Group Inc. increased its position in shares of Hims & Hers Health by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 14,173,285 shares of the company’s stock worth $126,142,000 after buying an additional 46,541 shares during the period. Institutional investors own 63.52% of the company’s stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.